Bluebirdbio stock.

Overview News bluebird bio Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.74 Market Cap $425.32 M Shares …Apple Inc. Common Stock. $191.6541 +1.9641 +1.04%. bluebird bio, Inc. Common Stock (BLUE) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global ... SOMERVILLE, Mass., March 29, 2023--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported financial results and business highlights for the fourth quarter and full year ...[relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of bluebird bio, Inc. (BLUE) bluebird bio, Inc. is a biotechnology company that focuses on developing gene therapies for severe genetic diseases and cancer. The company was founded in 1992 by a group of former employees of Genzyme, a biotechnology company …

Shares of the commercial-stage gene therapy company bluebird bio ( BLUE 3.55%) are having a strong session Wednesday. The biotech's stock was up by a noteworthy 18.8% on heavy volume as of 10:41 a ...Shares of bluebird bio (BLUE 2.64%) are down around 48% this year, but Wall Street analysts who follow the company expect better times ahead. The average price target on the stock implies a 99% gain.The current price bluebird bio (BLUE) is trading at is $3.87, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Popular Channels

Stock analysis for Bluebird Bio Inc (BLUE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

1. bluebird bio. Many biotech stocks soared last year. Not bluebird bio (BLUE-5.14%).Its shares plunged nearly 50%. While that certainly wasn't good for Bluebird shareholders, I think it makes the ...Bluebird (BLUE) delivered earnings and revenue surprises of 138.89% and 89.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?12 thg 7, 2023 ... Concerns over its cash runway and clinical trials are overblown, with the stock near all-time lows. ... bluebird bio's product pipeline (www.Mar 29, 2023 · SOMERVILLE, Mass., March 29, 2023--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported financial results and business highlights for the fourth quarter and full year ... Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $13.31M. -78.9%. Market Cap / Employee. The market cap of a ...

bluebird bio, Inc. (BLUE) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 4.2600 +0.4400 (+11.52%) At close: 04:00PM EST 4.3300 +0.07 (+1.64%) …

Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that the U.S. Food and Drug Administration (FDA) has approved Abecma (idecabtagene vicleucel; ide-cel) as the first B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of adult patients …

Mar 29, 2023 · SOMERVILLE, Mass., March 29, 2023--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported financial results and business highlights for the fourth quarter and full year ... Nov 8, 2021 · Shares of Bluebird Bio ( BLUE 2.64%) were plunging 19.3% lower as of 3:42 p.m. EST on Monday. The sharp decline came after two analysts downgraded Bluebird. Goldman Sachs ( GS 0.15%) analyst ... Get the latest bluebird bio, Inc. (BLUE) stock news and headlines to help you in your trading and investing decisions. Bluebird bio's blood disorder treatment demonstrates "clinically meaningful" benefit in patients, staff reviewers at the U.S. Food and Drug Administration said in briefing documents published on ...The high in the last 52 weeks of bluebird bio stock was 8.58. According to the current price, bluebird bio is 50.47% away from the 52-week high. What are analysts …Bluebird Bio (BLUE 11.52%) and CRISPR Therapeutics (CRSP 2.88%) are two rising biotechs that specialize in gene-editing therapies to treat rare genetic blood disorders and cancer.

bluebird bio Inc. Watch NEW Set a price target alert Open Last Updated: Nov 27, 2023 1:11 p.m. EST Real time quote $ 3.7650 -0.1250 -3.21% Previous Close $3.8900 Advanced Charting Volume: 2.77M...bluebird bio (BLUE) Stock Gains 25.6% in a Month: Here's How. bluebird bio (BLUE) rises 25.6% in past thirty days on upbeat earnings results and promising progress with its …We would like to show you a description here but the site won’t allow us.Shares of this under-the-radar cell therapy stock are set to double, says Baird. Published Tue, Mar 7 202312:39 PM EST Updated Tue, Mar 7 20231:46 PM EST. Michelle Fox @MFoxCNBC.Bluebird Bio has a market capitalization of around $425 million at the moment, so this small-cap biotech stock could see a significant increase in its share …Nov 26, 2023 · Target values for the price of one bluebird bio share for Nov 2025. The weighted average target price per bluebird bio share in Nov 2025 is: 8.72. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 19.746% volatility is expected. Pessimistic target level: 7.95. Optimistic target level: 9.91.

What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...bluebird bio, Inc. Announces Pricing of $120 Million Public Offering of Common Stock. SOMERVILLE, Mass. -- (BUSINESS WIRE)--Jan. 18, 2023-- bluebird bio, Inc. (Nasdaq: BLUE) (“bluebird”) today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock at a public offering price of $6.00 per …

Dec 1, 2023 · 12 analysts have issued 1-year price objectives for bluebird bio's shares. Their BLUE share price targets range from $3.00 to $13.00. On average, they expect the company's share price to reach $7.62 in the next twelve months. This suggests a possible upside of 95.9% from the stock's current price. Bluebird bio stock price target cut to $86 from $172 at Evercore ISI. 0. Canada Goose downgraded to buy from strong buy at CFRA. 0. Canada Goose stock price target cut to $50 from $65 at CFRA. 0. Children's Place downgraded as e-commerce puts margins at …Nov 26, 2023 · Bluebird Bio has a market capitalization of around $425 million at the moment, so this small-cap biotech stock could see a significant increase in its share price if it lands this historic approval. [relinking] Home Product Place Promotion Price Bluebird bio, Inc. (BLUE) reported a total revenue of $49.9 million in the third quarter of 2022. The company's net loss for the third quarter of 2022 was $116.7 million. Bluebird bio, Inc. (BLUE) had cash, cash equivalents, and marketable securities totaling $1.1 billion as of September 30, 2022. Bluebird bio, …Shares of Bluebird Bio (BLUE-3.00%) were plunging 22.3% as of 10:41 a.m. ET on Monday. ... Why Bluebird Bio Stock Soared 7% Higher on Tuesday. Is Bluebird Bio Stock a Buy?19 thg 5, 2017 ... The Technology Behind Bluebird Bio. 5.4K views · 6 years ago ...more ... Bluebird stock pops after FDA approves its gene therapy drug. Yahoo ...Bluebird Bio Inc (NASDAQ: BLUE) shares are trading lower Monday. The stock initially surged in premarket trading following the U.S. Food and Drug Administration's accelerated approval of ...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...

The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.

bluebird bio Inc (BLUE) stock is higher by 0.26% while the S&P 500 is down -0.11% as of 11:47 AM on Thursday, Nov 30. BLUE has risen $0.01 from the previous closing price of $3.86 on volume of 1,460,801 shares. Over the past year the S&P 500 is up 14.86% while BLUE is down -49.41%. BLUE lost -$0.74 per share in the over the last 12 …

10 thg 3, 2021 ... BLUE Stock Pops On Gene Therapy Analysis ... On the stock market today, BLUE stock jumped 8.1% to 32.48. Bluebird uses an empty virus to deliver ...Stock analysis for Bluebird Bio Inc (BLUE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Another factor that may be contributing to BLUE stock gaining ground today — which jumped 17% and is up nearly 22% at time of writing — centers on possible short-squeeze speculation. According ...Bluebird Bio BLUE Pre PDUFA Summary 04Dec2023Thank you for watching this video If you like it please like the video and subscribe to my page. Please excuse t...bluebird bio specializes in gene therapies for severe genetic diseases and has 2 FDA-approved products. EV/Sales multiple appears cheap. Find out why BLUE …Discover historical prices for BLUE stock on Yahoo Finance. View daily, weekly or monthly format back to when bluebird bio, Inc. stock was issued.Find real-time BLUE - bluebird bio Inc stock quotes, company profile, news and forecasts from CNN Business.Shares of bluebird bio (BLUE Quick Quote BLUE - Free Report) have increased by 25.6% in a month compared with the industry’s growth of 0.2%.. Last month, bluebird posted better-than-expected ...Nov 29, 2023 · Even Bluebird Bio (NASDAQ:BLUE) is waiting on a US FDA decision on its sickle cell treatment, lovo-cel.With a decision date set for Dec. 20, BLUE is already gaining momentum, running from about $2 ... Oct 20, 2021 · Key Points. Bluebird Bio's shares have dropped like a rock in recent years, and its new price tag makes the stock look more like a buy. The biotech boasts an exciting lineup of gene therapies for ...

Apr 6, 2023 · The case for buying the dip isn't exactly a slam dunk. With the stock down 52% in the last three months, Bluebird Bio ( BLUE -1.28%) shareholders are bound to be feeling pretty antsy. Between the ... If you're looking for growth stocks that are at the spear's tip of innovation, you might want to check out Bluebird Bio (BLUE 11.52%) and Arista Networks (ANET-1.40%).Shares of this under-the-radar cell therapy stock are set to double, says Baird. Published Tue, Mar 7 202312:39 PM EST Updated Tue, Mar 7 20231:46 PM EST. Michelle Fox @MFoxCNBC.Specifically, the biotech's stock is down by 11% as of 12:56 p.m. ET on Monday. Bluebird's shares are retreating today in response to two key issues: First, the company's 2021 fourth-quarter and ...Instagram:https://instagram. ex dividend date calenderfidelity margin rategoog atocknyse iot news Stock analysis for Bluebird Bio Inc (BLUE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. manulife financial corpmolina health care review Find the latest 2seventy bio, Inc. (TSVT) stock quote, history, news and other vital information to help you with your stock trading and investing. xly top holdings Jun 30, 2023 · Let's look at Bluebird Bio (BLUE 2.64%). Per Wall Street's analysts, its shares could rise 118% by this time next year despite losing 51% of their value so far in 2023. bluebird bio has received approval for their first products and are on track to treat their first patient later this year. Find out why BLUE stock is a hold.Even Bluebird Bio (NASDAQ:BLUE) is waiting on a US FDA decision on its sickle cell treatment, lovo-cel. With a decision date set for Dec. 20 , BLUE is already gaining momentum, running from about ...